Helland Christian A, Kråkenes Jostein, Moen Gunnar, Wester Knut
Department of Surgical Sciences, Section for Neurosurgery, University of Bergen, Bergen, Norway.
Neurosurgery. 2006 Dec;59(6):1168-75; discussion 1175-6. doi: 10.1227/01.NEU.0000245627.93215.BF.
Since the introduction of endovascular embolization, the optimal treatment of ruptured aneurysms has been debated. Much of this debate has been based on results from large neurovascular centers and may not be applicable to small neurosurgical centers with low annual aneurysm loads. We think that the results of small centers, such as ours, may also be of some interest.
This study included 286 patients treated endovascularly or operated on by the senior investigator (KW) before November 2004. They all had an angiographically verified aneurysm as the source of bleeding in the subarachnoid hemorrhage. Variables related to presentation, radiological findings, treatment, and outcome were recorded.
A significantly higher proportion (66.3%) of the endovascular patients had complete or near-complete recovery (Glasgow Outcome Scale 5) compared with the surgically treated patients (47.8%). When clinical outcomes were dichotomized into favorable (Glasgow Outcome Scale 4-5) and unfavorable (Glasgow Outcome Scale 1-3), no difference was found between the two treatment groups. Treatment-related mortality or morbidity was equal. Significantly more patients were converted from endovascular to surgical treatment than vice versa. No surgically treated patients rebled, whereas four endovascular patients rebled from their previously treated aneurysm.
At present in our hospital, the endovascular modality seems to yield a better clinical outcome than surgery and has become our treatment of choice. With increasing use and further refinement of the endovascular techniques, the difference in outcomes between the treatment modalities will probably change even further in favor of the endovascular technique.
自血管内栓塞术引入以来,破裂动脉瘤的最佳治疗方法一直存在争议。这场争论大多基于大型神经血管中心的结果,可能不适用于年动脉瘤负荷量低的小型神经外科中心。我们认为,像我们这样的小型中心的结果可能也有一定意义。
本研究纳入了2004年11月之前由资深研究者(KW)进行血管内治疗或手术治疗的286例患者。他们均经血管造影证实有动脉瘤,且该动脉瘤为蛛网膜下腔出血的出血源。记录与临床表现、影像学检查结果、治疗及预后相关的变量。
与接受手术治疗的患者(47.8%)相比,接受血管内治疗的患者中完全或近乎完全恢复(格拉斯哥预后量表评分为5分)的比例显著更高(66.3%)。当将临床结果分为良好(格拉斯哥预后量表评分为4 - 5分)和不良(格拉斯哥预后量表评分为1 - 3分)时,两个治疗组之间未发现差异。治疗相关的死亡率或发病率相当。从血管内治疗转为手术治疗的患者明显多于从手术治疗转为血管内治疗的患者。接受手术治疗的患者无一再出血,而4例接受血管内治疗的患者其先前治疗的动脉瘤再出血。
目前在我们医院,血管内治疗方式似乎比手术治疗能产生更好的临床效果,已成为我们的首选治疗方法。随着血管内技术的使用增加和进一步完善,治疗方式之间的疗效差异可能会进一步朝着有利于血管内技术的方向变化。